ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Care"

  • Abstract Number: 2235 • 2016 ACR/ARHP Annual Meeting

    Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By RA Patients: A 13 Year Population Health Study

    John G Hanly1, Kara Thompson2 and Chris Skedgel3, 1Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, 2Medicine, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, 3Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, United Kingdom

    Background/Purpose: To determine total and subspecialty physician encounters, emergency room (ER) visits and hospitalizations in an incident cohort of rheumatoid arthritis (RA) cases and matched…
  • Abstract Number: 3139 • 2016 ACR/ARHP Annual Meeting

    Breaking the Cycle: Analyzing Preventable Hospital Admissions Due to Gout

    Pieusha Malhotra1, Nikky Keer2 and Robert Yood3, 1Internal Medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA, 2Internal medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA, 3Department of rheumatology and musculoskeletal medicine, Department of Medicine, Division of Rheumatic Diseases and Musculoskeletal Medicine, Saint Vincent Hospital, Worcester, MA

    Background/Purpose: Despite available effective treatment options and published guidelines for gout management, many patients suffer from recurrent gout attacks. Increases in gout prevalence and continued…
  • Abstract Number: 2914 • 2015 ACR/ARHP Annual Meeting

    Modifiable and Non-Modifiable Correlates of Satisfaction with Care in Systemic Lupus Erythematosus

    Syed Alam1, Nisarg Gandhi2, Alana Nevares1, Ailda Nika2, Winston Sequeira2 and Meenakshi Jolly3, 1Internal Medicine, Cook County Hospital, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Systemic Lupus Erythematosus (SLE) a chronic disease, predominantly of young women, which may involve various organs, and is marked by periods of disease flares,…
  • Abstract Number: 846 • 2015 ACR/ARHP Annual Meeting

    Nationwide Trends in in-Hospital Mortality and Hospitalization Associated with Systemic Sclerosis (SSc)

    Sara R. Schoenfeld1, Na Lu1, Flavia V. Castelino2, Marcy B. Bolster2 and Hyon K. Choi1, 1Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Allergy, Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Patients with systemic sclerosis (SSc) experience high rates of morbidity and mortality, but few studies have evaluated health care utilization such as hospitalization rates…
  • Abstract Number: 921 • 2015 ACR/ARHP Annual Meeting

    Poverty Associated with Increase in Damage in SLE over Two-Year Period

    Edward H. Yelin1, Laura Trupin2, Jinoos Yazdany2 and Stephanie Rush3, 1University of California, San Francisco, San Francisco, CA, 2Rheumatology, UCSF, SF, CA, 3UCSF, SF, CA

    Background/Purpose:   Prior research has shown that persons with SLE in poverty have fewer physician visits for SLE and receive lower technical quality of care.…
  • Abstract Number: 1293 • 2015 ACR/ARHP Annual Meeting

    A Comparison of Prenatal Care  in Mothers with and without JIA: Association with Outcomes

    Debbie Ehrmann Feldman1, Anick Bérard2, Evelyne Vinet3, Ciarán M. Duffy4, Elizabeth Hazel5, Marie-Pierre Sylvestre6, Garbis Meshefedjian7 and Sasha Bernatsky8, 1School of Rehabilitation, Université de Montréal, Montreal, QC, Canada, 2Université de Montréal, Montréal, QC, Canada, 3Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 4Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 5Rhematology, McGill University Health Centre, Montreal, QC, Canada, 6Université de Montréal, Montreal, QC, Canada, 7Public Health Department of Montreal, Montreal, QC, Canada, 8Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada

    Background/Purpose: Women who had JIA in childhood and adolescence may be at higher risk for adverse neonatal and maternal outcomes. Our objective was to examine…
  • Abstract Number: 2106 • 2015 ACR/ARHP Annual Meeting

    Intensification to Triple Therapy Non-Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States from 2009 to 2014

    Jeffrey A. Sparks1, Alexis A. Krumme2, Olga S. Matlin3, Gregory Brill2, William H. Shrank3, Niteesh K. Choudhry2 and Daniel H. Solomon2,4, 1Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3CVS Caremark, Woonsocket, RI, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Several trials suggest that triple therapy with non-biologic disease-modifying antirheumatic drugs (ttDMARD) has similar efficacy compared to biologic DMARDs (bDMARD) for patients with RA.…
  • Abstract Number: 2259 • 2015 ACR/ARHP Annual Meeting

    Incidence of Obesity, Diabetes and High Blood Pressure Associated with Arthritis: Analysis of the Canadian Longitudinal National Population Health Survey

    Orit Schieir1, Sheilah. Hogg-Johnson1,2, Richard H Glazier3,4,5,6 and Elizabeth M. Badley1,7, 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 2Institute for Work and Health, Toronto, ON, Canada, 3Family and Community Medicine, St. Michael's Hospital, Toronto, ON, Canada, 4Centre for Research on Inner City Health, St. Michael's Hospital, Toronto, ON, Canada, 5Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 6Family and Community Medicine, University of Toronto, Toronto, ON, Canada, 7Health Care & Outcomes Research, Toronto Western Res. Institute, Toronto, ON, Canada

    Background/Purpose: While cross-sectional evidence points to a higher prevalence of cardiovascular (CVD) risk factors in persons with arthritis, longitudinal population based studies are lacking. The…
  • Abstract Number: 2902 • 2014 ACR/ARHP Annual Meeting

    The Health Status of Patients with Juvenile Idiopathic Arthritis (JIA) Significantly Worsens after Transfer from Pediatric to Adult Care

    Kirsten Minden1, Jens Klotsche2, Martina Niewerth2, Angela Zink3 and Gerd Horneff4, 1Chidlrens´ hospital, Charité University Medicine, Berlin, Germany, 2Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, 3German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 4Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany

    Background/Purpose A minority of patients with polyarticular JIA enter adulthood in drug free remission. Thus, patients are in need of care beyond adolescence. There is…
  • Abstract Number: 2406 • 2014 ACR/ARHP Annual Meeting

    Primary Non-Adherence, Associated Clinical Outcomes and Healthcare Resource Utilization Among Rheumatoid Arthritis Patients Prescribed Injectable Biologics

    J. Harnett1, D. Wiederkehr1, R. Gerber2, D. Gruben2, J. Bourret3 and A. Koenig3, 1Pfizer Inc, New York, NY, 2Pfizer Inc, Groton, CT, 3Pfizer Inc, Collegeville, PA

    Background/Purpose: Injectable biologics are commonly used to treat patients (pts) with moderate to severe rheumatoid arthritis (RA); the frequency with which they are prescribed but…
  • Abstract Number: 2116 • 2014 ACR/ARHP Annual Meeting

    Hospitalization Rates and Utilization Among Rheumatoid Arthritis Patients: A Population-Based Study from 1987 to 2012

    C. John Michet III1, Katrina Strobova2, Sara J. Achenbach3, Cynthia S. Crowson4 and Eric L. Matteson5, 1Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, 2Department of Medicine, Charles University, Prague, Czech Republic, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Health Sciences Research, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose Patients with rheumatoid arthritis (RA) experience chronic management issues and are at risk for complex comorbidities. It is unknown, however, to what extent the…
  • Abstract Number: 2067 • 2014 ACR/ARHP Annual Meeting

    Understanding the Factors Influencing Time to Diagnosis in Fibromyalgia

    Howard Amital1, Yaeli Bar-On2, Varda Shalev3, Dahlia Weitzman3 and Gabriel Chodick4, 1Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 2Department of Medicine E,, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel, 3Medical Informatics, Maccabi Healthcare Services, Tel Aviv, Tel-Aviv, Israel, 4Medical Informatics, Healthcare Services, Tel Aviv, Tel-Aviv, Israel

    Background/Purpose - Fibromyalgia (FM) is a chronic debilitating disorder considered to be part of a spectrum of central sensitization syndromes. The diagnosis of FM is…
  • Abstract Number: 2029 • 2014 ACR/ARHP Annual Meeting

    Treatment Patterns of Multimorbid Rheumatoid Arthritis Patients: Results from an International Cross-Sectional Study

    Helga Radner1,2, Kazuki Yoshida3,4, Ihsane Hmamouchi5, Maxime Dougados6,7, Josef Smolen8 and Daniel H Solomon9, 1Department of Internal Medicine III; Division of Rheumatology, Medical University Vienna, Vienna, Austria, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 3Department of Rheumatology, Kameda Medical Center, Kamogawa, Japan, Kamogawa, Japan, 4Division of Rheumatology, Brigham and Women’s Hospital, Boston, MA, 5Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, 6Descartes University, Cochin Hospital, Paris, France, 7INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France, 8Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 9Rheumatology, Brigham and Women's Hospital, Boston, MA

    Treatment Patterns of Multimorbid Rheumatoid Arthritis Patients: Results from an International Cross-sectional StudyBackground/Purpose The presence of multimorbidity could lead to less intensive treatment of RA.…
  • Abstract Number: 1693 • 2014 ACR/ARHP Annual Meeting

    Progressive Disease in Systemic Sclerosis after One Year of Follow-up;  Results of a Standardized Multidisciplinary Health Care Program

    Jessica Meijs1, Anne Schouffoer2, Nina Ajmone Marsan3, Lucia Kroft4, Maarten K. Ninaber5, T.W.J. Huizinga1 and Jeska K. De Vries-Bouwstra1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Cardiology, Leiden University Medical Center, Leiden, Netherlands, 4Deparment of Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Pulmonology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The aim of this study is to evaluate disease course of systemic sclerosis (SSc) patients participating in a single centre multidisciplinary health-care program over…
  • Abstract Number: 1299 • 2014 ACR/ARHP Annual Meeting

    A Cross-Sectional Study of Mental Health Symptoms and Mental Health Care in Pediatric SLE/MCTD Patients and Their Peers

    Andrea Knight1,2, Michelle Vickery1, Pamela Weiss1,2,3, Knashawn Morales3 and Ron Keren3,4, 1Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 2Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 3Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Mental health problems are prevalent in pediatric systemic lupus erythematosus (SLE). We aimed to compare the rates of mental health problems and mental health…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology